Table of Contents Author Guidelines Submit a Manuscript
International Journal of Photoenergy
Volume 2015, Article ID 583052, 6 pages
http://dx.doi.org/10.1155/2015/583052
Research Article

Photostability of Loratadine Inclusion Complexes with Natural Cyclodextrins

Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, Rua do Lago 250, Prédio Semi-Industrial, Cidade Universitária, Butantã, 05508-080 São Paulo, SP, Brazil

Received 20 October 2015; Accepted 10 December 2015

Academic Editor: Iqbal Ahmad

Copyright © 2015 Patricia Elizabeth Rivas-Granizo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. H. Tønnesen, “Formulation aproaches for improving solubility and its impact on drug photostability,” in Photostability of Drugs and Drug Formulations, H. H. Tønnesen, Ed., pp. 351–372, CRC Press, Boca Raton, Fla, USA, 2004. View at Google Scholar
  2. A. C. Kogawa, A. Zoppi, M. A. Quevedo, H. R. Nunes Salgado, and M. R. Longhi, “Increasing doxycycline hyclate photostability by complexation with β-cyclodextrin,” AAPS PharmSciTech, vol. 15, no. 5, pp. 1209–1217, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Ioele, M. De Luca, L. Tavano, and G. Ragno, “The difficulties for a photolabile drug in topical formulations: the case of diclofenac,” International Journal of Pharmaceutics, vol. 465, no. 1-2, pp. 284–290, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Jamrógiewicz, B. Wielgomas, and M. Strankowski, “Evaluation of the photoprotective effect of β-cyclodextrin on the emission of volatile degradation products of ranitidine,” Journal of Pharmaceutical and Biomedical Analysis, vol. 98, pp. 113–119, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. E. M. M. Del Valle, “Cyclodextrins and their uses: a review,” Process Biochemistry, vol. 39, no. 9, pp. 1033–1046, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Mielcarek and E. Daczkowska, “Photodegradation of inclusion complexes of isradipine with methyl-β-cyclodextrin,” Journal of Pharmaceutical and Biomedical Analysis, vol. 21, no. 2, pp. 393–398, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. D. A. Godwin, C. J. Wiley, and L. A. Felton, “Using cyclodextrin complexation to enhance secondary photoprotection of topically applied ibuprofen,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 62, no. 1, pp. 85–93, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Ioele, M. Luca, and G. Ragno, “Photostability of barnidipine in combined cyclodextrin-in-liposome matrices,” Future Medicinal Chemistry, vol. 6, no. 1, pp. 35–43, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Ragno, A. Risoli, G. Loele, E. Cione, and M. De Luca, “Photostabilization of 1,4-dihydropyridine antihypertensives by incorporation into β-cyclodextrin and liposomes,” Journal of Nanoscience and Nanotechnology, vol. 6, no. 9-10, pp. 2979–2985, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. S. P. Clissold, E. M. Sorkin, and K. L. Goa, “Loratadine,” Drugs, vol. 37, pp. 42–57, 1989. View at Google Scholar
  11. K.-G. Wu, T. H. Li, T. Y. Wang, C. L. Hsu, and C. J. Chen, “A comparative study of loratadine syrup and cyproheptadine HCL solution for treating perennial allergic rhinitis in taiwanese children aged 2–12 years,” International Journal of Immunopathology and Pharmacology, vol. 25, no. 1, pp. 231–237, 2012. View at Google Scholar · View at Scopus
  12. M. B. Abelson and A. P. Kaplan, “A randomized, double-blind, placebo-controlled comparison of emedastine 0.05% Ophthalmic solution with loratadine 10 mg and their combination in the human conjunctival allergen challenge model,” Clinical Therapeutics, vol. 24, no. 3, pp. 445–456, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Y. Başak, H. Vural, O. O. Kazanoglu, I. Erturan, and H. I. Buyukbayram, “Effects of loratadine and cetirizine on serum levels of neuropeptides in patients with chronic urticaria,” International Journal of Dermatology, vol. 53, no. 12, pp. 1526–1530, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Omar, M. I. El-Barghouthi, N. A. Masoud et al., “Inclusion complexation of loratadine with natural and modified cyclodextrins: phase solubility and thermodynamic studies,” Journal of Solution Chemistry, vol. 36, no. 5, pp. 605–616, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. H.-L. Lin, S.-Y. Lin, C.-C. Lin, C.-H. Hsu, T.-K. Wu, and Y.-T. Huang, “Mechanical grinding effect on thermodynamics and inclusion efficiency of loratadine-cyclodextrin inclusion complex formation,” Carbohydrate Polymers, vol. 87, no. 1, pp. 512–517, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Pooja, B. Meenakshi, and S. Shruti, “Physicochemical characterization and dissolution enhancement of loratadine—Hydroxypropyl-β-cyclodextrin binary systems,” Journal of Pharmaceutical Sciences and Research, vol. 3, no. 4, pp. 1170–1175, 2011. View at Google Scholar · View at Scopus
  17. S.-Y. Lin, C.-H. Hsu, and M.-T. Sheu, “Curve-fitting FTIR studies of loratadine/hydroxypropyl-β-cyclodextrin inclusion complex induced by co-grinding process,” Journal of Pharmaceutical and Biomedical Analysis, vol. 53, no. 3, pp. 799–803, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Szabados-Nacsa, P. Sipos, T. Martinek et al., “Physico-chemical characterization and in vitro/in vivo evaluation of loratadine:dimethyl-β-cyclodextrin inclusion complexes,” Journal of Pharmaceutical and Biomedical Analysis, vol. 55, no. 2, pp. 294–300, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. Á. Nacsa, O. Berkesi, P. Szabó-Révész, and Z. Aigner, “Achievement of pH-independence of poorly-soluble, ionizable loratadine by inclusion complex formation with dimethyl-β-cyclodextrin,” Journal of Inclusion Phenomena and Macrocyclic Chemistry, vol. 64, no. 3-4, pp. 249–254, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. Iternational Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Q1B Stability Testing: Photostability Testing of New Drug Substances and Products, 1996.
  21. Iternational Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, “Guideline Q2(R1): Validation of Analytical Procedures: Text and Methodology,” 2005.
  22. S. Sortino, S. Giuffrida, G. De Guidi et al., “The photochemistry of flutamide and its inclusion complex with β-cyclodextrin. Dramatic effect of the microenvironment on the nature and on the efficiency of the photodegradation pathways,” Photochemistry and Photobiology, vol. 73, no. 1, pp. 6–13, 2001. View at Publisher · View at Google Scholar · View at Scopus